Publications by authors named "Signorelli Mirko"

Claim this Profile
D
Dynamic prediction of survival using multivariate functional principal component analysis: A strict landmarking approach.
Daniel Gomon, Hein Putter, Marta Fiocco, Mirko Signorelli

Stat Methods Med Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers.
Camilla Johansson, Helian Hunt, Mirko Signorelli, Fredrik Edfors, Andreas Hober

Clin Proteomics· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomic characterization of disease progression in mice lacking dystrophin.
Mirko Signorelli, Roula Tsonaka, Annemieke Aartsma-Rus, Pietro Spitali

PLoS One· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Assessment of Creatine Kinase, Creatine/Creatinine, and Myostatin as Monitoring Biomarkers in Becker Muscular Dystrophy.
Nienke M van de Velde, Zaïda Koeks, Mirko Signorelli, Nisha Verwey, Maurice Overzier

Neurology· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penalized regression calibration: A method for the prediction of survival outcomes using complex longitudinal and high-dimensional data.
Mirko Signorelli, Pietro Spitali, Cristina Al-Khalili Szigyarto, , Roula Tsonaka

Stat Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood transcriptome profiling enables monitoring disease progression in dystrophic mice and patients.
Mirko Signorelli, Mitra Ebrahimpoor, Olga Veth, Kristina Hettne, Nisha Verwey

EMBO Mol Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.
Kristin Strandberg, Burcu Ayoglu, Andreas Roos, Mojgan Reza, Erik Niks, Mirko Signorelli

J Neuromuscul Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy.
Stefano C Previtali, Teresa Gidaro, Jordi Díaz-Manera, Alberto Zambon, Stephanie Carnesecchi, Mirko Signorelli

Pharmacol Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy.
Mirko Signorelli, Burcu Ayoglu, Camilla Johansson, Hanns Lochmüller, Volker Straub

J Cachexia Sarcopenia Muscle· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models.
Roula Tsonaka, Mirko Signorelli, Ekrem Sabir, Alexandre Seyer, Kristina Hettne

Hum Mol Genet· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEAT: an efficient network enrichment analysis test.
Mirko Signorelli, Veronica Vinciotti, Ernst C Wit

BMC Bioinformatics· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis